MainImg

The Swiss Medicine & Pharmaceuticals,

Consultation In Applied Research Using Ai & ML @ Institute Of Bio Medical Engineering, Applied Research Using BigData in Public Health




    Non Prejudicial Disclosure, Intellectual Property: Solution Design Using Ai in Bio Medical Engineering,
    Date: Jun 14, 2023
    Thretre: Development Country Applied Research: Ai in Public Health Care

    Contagious and Infectious Disease
    Laboratory Medical Science & Engineering - Cancer, HIV, Diabetes, HPV Research and Heredity Blood, Water Borne Diseases


    Case 26:Peptic Ulcer,
    Sinus Tachycardia,
    Non specific Twave abnormality,
    Left Atrial Enlargement- Diagnosis:



    Our patient is a over fifty male with symptoms of bloated stomach, flu-cold, running nose and congestion, complaints he feels uneasy to walk and sometimes suffers from sleepless-ness. In order to diagnose if he suffers from H. pylori infection, blood pressure 180/100 (high) we adopt the following tests:

    .

    We used

  • Vitors 5600/Advia Centaur Xpt/Immulite 2000 XPi/Liaison / Maglumi 2000 Plus Random Access Immunoassay Analyzer,
  • Urised 3 and Labumat Urine Analyzer
  • Atellica Siemens Automated Analyzer

  • Vitros ECI /Advia Centaur XP/Architect I 1000 SR/Liaison Random Access
  • Checked Manually


    a) Electrocardiogram:


    Finding in the ECG test, are:

    Vent rate 102 bpm
    PR int 134 ms
    QRS dur 84 ms
    QT/QTc int 336/395 ms
    P/QRS/ T axis 46/10/4
    RV5/SV1 amp 1.165/ 1.295 mV
    RV5 SV1 amp 2.460 mV
    we apply filer of 10 mm/mV 25 mm/s filter : H60 D 35 Hz

    the ECG result reports:

    1120 Sinus Tachycardia
    4068 Non specific Left Atrial enlargement
    and
    9140 an abnormal rhythm ECG.


    b)Hematology:

    Applying estimation carried out by Sysmex-XN-1000 & Ves-Matic 80/CUBE 30 Touch ESR Analyzer, we have:


    Red Blood Cell: (vs reference values)


    Haemoglobin 14.0 g/dL within the range of 15.0 +,-,2
    Total RBC 5.08 million /cmm within range of 5.0,+,-,0.5
    ESR 15 mm (auto Analyzer) 0-10
    PCV/HCT 42.6% Men 45,+,-, 5
    MCV 83.0 fL 92,+,-,9
    MCH 27.6 pg 29.5 + _ 2.5
    MCHC 32.9 g/dL 33.0 + - 1.5
    RDW-CV 13.3% 12.8 +,- 1.2
    Nucleated Red Blood Cell 0.0%


    White Blood Cell:


    Total WBC 9760/Cmm <11000
    Circulating Eosinophis 195/Cmm 5- -500


    Differential Count

    Neutrophils 57% <75
    Lymphocytes 38% <40
    Monocytes 03% <10
    Eosinophils 02% <6
    Basophils 00% <1.0


    Platelet Count


    Total Platelet count 30100 /Cmm <450000
    MPV 11.5 fL 8.0-9.5





    c) Bio chemistry:

    Diagnosed by Siemens Dimension ExL Max /EXL200/VIT5600 Random Access Chemistry Analyzer


    Lipase 244 U/L <23-300








 

 


    Application of ML, Ai Research Bio Medical Engineering, Case Study Analysis:



    Research & Development - Gastro Intestine Tract, Bio Medical Engineering - Imaging Sciences




    e) Diagnosing USG Whole abdomen, for Fatty Change in Liver (grade II) and Enlarge prostate.


    Ultra sonogram:

    Ultra sonogram:- our findings:

    liver: is enlarged (16.1 cm in length) Echogenicity of liver parenchyma is moderately increased with homogenous echotexture. No focal lesion is seen.
    Intrahepatic vessels ar well visualized, Inferior vena cava , hepatic veins are normal in caliber.
    Gall Bladder is normal in size. Wall thickness is within normal limits. Lumen is clear.
    Common bile duct and intrahepatic biliary channels are not dilated. Main pancreatic duct is not dilated.
    Spleen is normal in size (9.2 cm) with homogeneous echotexture.
    Both Kidneys are normal in size (bipolar length of RFK i s10.5 cm and that of LK is 10.3 cm) with normal shape and position. Cortices and medullae are well defined. Pelvicalyceal systems are not dilated.

    Urinary Bladder is well filled. Wall thickness is within normal limit.

    Prostate is enlarged (volume 35.3 cc) with uniform echotexture.

    Impression of diagnostics:


    Patient suffers from Fatty change in liver (grade II)
    Enlarged prostate.


    We record Collected test results in Big Data to advance preventative medicine, for strain specific model establishment for mutation analysis.



    d) Endoscopic Procedure:


    in order to investigate Peptic Ulcer /ulcer in the intestine of gastro intestine, we use Olympus, CV -190
    procedure: we perform, upper G.I Tract endoscope with CLO (Campylobacter-like organism test), to investigate stomach.
    Medication we used is: Simethicone drop with xylocaine spray, we found we found CLO test positive.


    Oesophagus: the mucosa ,vascular pattern and Lumen and peristalsis appear normal.
    Both upper and lower oesophagus sphincters are normal. No varix is seen.


    stomach: Quite a bit erosions are noted at the gastric antrum. Rest of the part appears normal.


    Duodenum: The bulb shows ulcers and the mucosa of the duodenal second part is inflamed.
    Biopsy: Not taken
    CLO: position
    Our findings Peptic Ulcer disease.

    Rx and Medication:

    Tablet : Sergel Mups 40 mg, twice 1+0+1 two months
    (gas)Gavisol twice spoonful , twice after food consumption,
    Tablet: Domin 1 mg two months twice a day 1+0+1
    (peptce Ulcer) Tab Esotid twice four tablet each time 14 days 4+0+4
    for Prostate: Cap uromax continuously once aa day 0+0+1
    tablet ursocol 150 mg two months twice a day ,two months, 1+0+1




    Note: A3iNet is a hybrid Deep Learning HDNN, Neural Network Systems, applied to Complex Systems Of Systems' Scientific and Industrial Systems Integration as Solution enforced with Ai for Large Scale Enterprise Integration, LSSI, developed by Swedish World Wide & Aerovition Digital Inc..











 




 

--